{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T13:10:24Z","timestamp":1739884224347,"version":"3.37.3"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/hjh.0b013e3283346b62","type":"journal-article","created":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T05:09:39Z","timestamp":1266037779000},"page":"536-542","source":"Crossref","is-referenced-by-count":10,"title":["Involvement of mineralocorticoid receptor in high glucose-induced big mitogen-activated protein kinase 1 activation and mesangial cell proliferation"],"prefix":"10.1097","volume":"28","author":[{"given":"Gang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang-Ping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Suzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohisa","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyasu","family":"Kiyomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Yoshizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"R2-17-20210208","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1523-1755.2004.00913.x","article-title":"Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats","volume":"66","author":"Fujisawa","year":"2004","journal-title":"Kidney Int"},{"key":"R3-17-20210208","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.bjp.0704131","article-title":"Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats","volume":"133","author":"Miric","year":"2001","journal-title":"Br J Pharmacol"},{"key":"R4-17-20210208","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"R5-17-20210208","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-17-20210208","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study","volume":"28","author":"Rossing","year":"2005","journal-title":"Diabetes Care"},{"key":"R7-17-20210208","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"R8-17-20210208","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2310\/JIM.0b013e31816d78e9","article-title":"Effects of additive therapy with spironolactone on proteinuria in diabetic patients already on ACE inhibitor or ARB therapy: results of a randomized, placebo-controlled, double-blind, crossover trial","volume":"56","author":"Saklayen","year":"2008","journal-title":"J Invest Med"},{"key":"R9-17-20210208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000025912","article-title":"Progression of diabetic nephropathy. Insights from cell culture studies and animal models","volume":"22","author":"Phillips","year":"1999","journal-title":"Kidney Blood Press Res"},{"key":"R10-17-20210208","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s001250051439","article-title":"Mitogen-activated protein kinases as glucose transducers for diabetic complications","volume":"42","author":"Tomlinson","year":"1999","journal-title":"Diabetologia"},{"key":"R11-17-20210208","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1523-1755.2004.00576.x","article-title":"BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions","volume":"65","author":"Suzaki","year":"2004","journal-title":"Kidney Int"},{"key":"R12-17-20210208","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","article-title":"Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats","volume":"43","author":"Nishiyama","year":"2004","journal-title":"Hypertension"},{"key":"R13-17-20210208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/01.HYP.0000154681.38944.9a","article-title":"Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability","volume":"45","author":"Nishiyama","year":"2005","journal-title":"Hypertension"},{"key":"R14-17-20210208","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells","volume":"16","author":"Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R15-17-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol Rev"},{"key":"R16-17-20210208","doi-asserted-by":"crossref","first-page":"26563","DOI":"10.1074\/jbc.274.37.26563","article-title":"Activation of the protein kinase ERK5\/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus","volume":"274","author":"Kamakura","year":"1999","journal-title":"J Biol Chem"},{"key":"R17-17-20210208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.HYP.0000172622.51973.f5","article-title":"Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation","volume":"46","author":"Ishizawa","year":"2005","journal-title":"Hypertension"},{"key":"R18-17-20210208","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"R19-17-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol Rev"},{"key":"R20-17-20210208","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1074\/jbc.270.21.12665","article-title":"Components of a new human protein kinase signal transduction pathway","volume":"270","author":"Zhou","year":"1995","journal-title":"J Biol Chem"},{"key":"R21-17-20210208","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1254\/jphs.91.172","article-title":"Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases","volume":"91","author":"Yoshizumi","year":"2003","journal-title":"J Pharmacol Sci"},{"key":"R22-17-20210208","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.0000174593.88899.68","article-title":"Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1\/2 in rat renal fibroblasts","volume":"46","author":"Nagai","year":"2005","journal-title":"Hypertension"},{"issue":"134","key":"R23-17-20210208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000060149","article-title":"Mesangial cell dysfunction as a pathogenesis of diabetic nephropathy.","author":"Haneda","year":"2001","journal-title":"Contrib Nephrol"},{"key":"R24-17-20210208","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1053\/ajkd.2001.27438","article-title":"Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway","volume":"38","author":"Haneda","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R25-17-20210208","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1093\/ndt\/gfn333","article-title":"The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation","volume":"23","author":"Dorado","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R26-17-20210208","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.HYP.0000175814.18550.c0","article-title":"Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor","volume":"46","author":"Xue","year":"2005","journal-title":"Hypertension"},{"key":"R27-17-20210208","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1681\/ASN.2005020129","article-title":"Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1\/2, cyclin D1, and cyclin A","volume":"16","author":"Terada","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R28-17-20210208","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata","year":"2008","journal-title":"Nat Med"},{"key":"R29-17-20210208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.RES.76.6.973","article-title":"Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells","volume":"76","author":"Wehling","year":"1995","journal-title":"Circ Res"},{"key":"R30-17-20210208","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/HJH.0b013e328300a232","article-title":"Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions","volume":"26","author":"Wang","year":"2008","journal-title":"J Hypertens"},{"key":"R31-17-20210208","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1681\/ASN.V134894","article-title":"Role of high glucose-induced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells","volume":"13","author":"Ha","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R32-17-20210208","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-005-2344-2","article-title":"Mineralocorticoid receptors: distribution and activation","volume":"10","author":"Funder","year":"2005","journal-title":"Heart Fail Rev"},{"key":"R33-17-20210208","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00109-008-0343-1","article-title":"Aldosterone in salt-sensitive hypertension and metabolic syndrome","volume":"86","author":"Fujita","year":"2008","journal-title":"J Mol Med"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-201003000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T12:31:30Z","timestamp":1739881890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201003000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3283346b62","relation":{},"ISSN":["0263-6352"],"issn-type":[{"type":"print","value":"0263-6352"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}